Recent Developments in β-Lactamases and Inhibitors (Q58089146)

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Epidemiology and control of antibiotic resistance in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Global challenge of multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Emerging carbapenemases in Gram-negative aerobes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Beta-lactamase inhibitors from laboratory to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Beta-lactamase nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

The new beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Extended-spectrum beta-lactamases in long-term-care facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Minor extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Modeling study on a hydrolytic mechanism of class A beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

The Acylation Mechanism of CTX-M β-Lactamase at 0.88 Å Resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Metallo-beta-lactamases: the quiet before the storm?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Class A carbapenemases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Carbapenemases: the versatile beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases † , ‡

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Nosocomial outbreak of genetically related IMP-1 beta-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

68Zn isotope exchange experiments reveal an unusual kinetic lability of the metal ions in the di-zinc form of IMP-1 metallo-beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Crystal Structure of Pseudomonas aeruginosa SPM-1 Provides Insights into Variable Zinc Affinity of Metallo-β-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Structural basis for the role of Asp-120 in metallo-beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Asp-120 locates Zn2 for optimal metallo-beta-lactamase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Rapid and widespread dissemination of multidrug-resistant blaCMY-2 Salmonella Typhimurium in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore design

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Probing, inhibition, and crystallographic characterization of metallo-beta-lactamase (IMP-1) with fluorescent agents containing dansyl and thiol groups

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Competitive Inhibitors of the CphA Metallo- -Lactamase from Aeromonas hydrophila

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Spirocyclopropyl beta-lactams as mechanism-based inhibitors of serine beta-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Penicillin-derived inhibitors that simultaneously target both metallo- and serine-beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Synthesis and beta-lactamase reactivity of alpha-substituted phenaceturates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Inhibition of class D beta-lactamases by diaroyl phosphates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Inhibition of class D beta-lactamases by acyl phosphates and phosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

6-(substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. III. Structure-activity relationships of the 5-membered heterocyclic derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

A novel, mild, and facile method to prepare 6-methylidene penem derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

On the absolute configuration in 1,4-dihydrothiazepine covalent complexes derived from inhibition of class A and C beta-lactamases with 6-methylidene penems

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Inhibition of OXA-1 beta-lactamase by penems

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Comparison of -lactamases of classes A and D: 1.5-A crystallographic structure of the class D OXA-1 oxacillinase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Inhibition of Class A and Class C β-Lactamases by Penems: Crystallographic Structures of a Novel 1,4-Thiazepine Intermediate,

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Mechanism of inactivation of beta-lactamases by novel 6-methylidene penems elucidated using electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021

Crystal structure of BRL 42715, C6-(N1-methyl-1,2,3-triazolylmethylene)penem, in complex with Enterobacter cloacae 908R beta-lactamase: evidence for a stereoselective mechanism from docking studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-7743%2808%2900015-8

7 January 2021